Patient-Derived Xenograft Models for Leukemias

Area of Science:

• Hematology
• Oncology
• Animal Models

Background:

• Patient-derived xenograft (PDX) models are essential for studying leukemia pathogenesis, progression, and treatment efficacy.
• These models involve engrafting human leukemia cells into immunocompromised mice.

Purpose of the Study:

• To outline a reproducible method for generating PDX models from Acute Myeloid Leukemia (AML) patient samples.
• To demonstrate the applicability of this method for T- and B- Acute Lymphoblastic Leukemia (ALL) samples.

Main Methods:

• Human leukemia cells are injected into the tail vein of preconditioned immunocompromised mice.
• Mice are housed in sterile conditions until leukemia engraftment is confirmed.
• Established PDX models allow for subsequent studies, including drug treatment and sample collection.

Main Results:

• Successful generation of PDX models from AML patient samples.
• The described tail vein injection method is adaptable for ALL samples.

Conclusions:

• The described PDX modeling technique provides a valuable platform for leukemia research.
• This method facilitates the study of leukemia biology and therapeutic responses in vivo.